Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
CMS Launches Voluntary Prior Authorization Model for Traditional Medicare

Jul 22, 2025/News

Following discussions with major health insurers on their commitments, including a pledge to reduce the number of services requiring prior authorization, the Centers for Medicare & Medicaid Services announced its Wasteful and Inappropriate Service Reduction, or WISeR, model. This model aims to selectively

Better Together

Oct 1, 2020/Column

The power of teamwork, dramatically illustrated.

The Legacy of Vilma Evans, a Pioneering Black Physical Therapy Leader

Feb 3, 2026/Podcast

APTA Vice President of Advancement Carmen Elliott sits down with Milly Polovich, a former patient of the pioneering Black physical therapist Vilma Evans.

A Focus on Service: Are You In?

Sep 22, 2021/News

Spend a day (or more) to help us round out APTA's centennial year with a reinvestment in community.

Briar Cliff University Wins 2024 APTA Student Advocacy Challenge

May 8, 2025/Article

The Iowa program mobilized students in several ways to earn the top spot.

Get to Know APTA Academy of Clinical Electrophysiology & Wound Management: An Interview With Academy President Stephanie Woelfel

Jul 1, 2025/Podcast

University of Southern California Division of Biokinesiology and Physical Therapy, interviews Stephanie Woelfel, PT, DPT, president of APTA Academy of Clinical Electrophysiology & Wound Management. Learn more about these two clinical specialties that both reward curiosity and problem-solving.

2025 APTA House of Delegates Motions Posted

Jun 3, 2025/News

APTA members can now access 48 motions that include seven proposed bylaws amendments that will be forwarded for consideration by the 2025 APTA House of Delegates when it convenes July 13-14 in Washington, D.C.

Berg Balance Scale (BBS) for Stroke

Jun 5, 2013/Test & Measure

Measures balance.

Rivermead Mobility Index for Multiple Sclerosis (MS)

Sep 12, 2013/Test & Measure

Target population: People with multiple sclerosis (MS).